Harnessing Boron‐Mediated Ti Valence Cycling in TiB 2 ‐PEG‐DOX: A Multimodal CDT/PTT/CT Platform for Colorectal Cancer Therapy
Small · 2026
DOI: 10.1002/smll.202514529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Yueguang Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals and School of Chemical Engineering, Dalian University of Technology, 2 Linggong Road, Dalian, P. R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Doxorubicin, Polyethylene Glycols, Titanium. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities of China, Science and Technology Plan Project of Liaoning Province.
Abstract (Originalsprache)
Titanium‐based materials hold great biomedical potential owing to excellent biocompatibility. But titanium diboride (TiB 2 ), an emerging metal boride, is rarely explored for antitumor use, and developing multifunctional TiB 2 ‐based nanoplatforms with enhanced catalytic activity is urgently needed. Herein, we constructed a nanoplatform (TiB 2 ‐PEG‐DOX) by modifying TiB 2 nanosheets (TiB 2 NSs) with amino polyethylene glycol (NH 2 ‐PEG‐NH 2 ) and loading doxorubicin (DOX) via electrostatic interaction. We first clarified the boron (B)‐mediated Ti valence cycle: B regulates Ti electron transfer, promotes Ti 4+ reduction to Ti 2+ , enhancing H 2 O 2 ‐rich tumor microenvironment Fenton‐like reaction to generate cytotoxic •OH for chemodynamic therapy (CDT). Meanwhile, TiB 2 ‐PEG‐DOX shows 53.53% photothermal conversion efficiency under 808 nm near‐infrared (NIR) irradiation for efficient photothermal therapy (PTT), and NIR further triggers on‐demand DOX release. DOX accumulates at tumor sites via the enhanced permeability and retention (EPR) effect to exert chemotherapy (CT). In vitro, it eliminates 86.32% of HCT‐116 colorectal cancer cells via CDT/PTT/CT synergy; in vivo, it achieves nearly complete tumor ablation in mice with excellent biocompatibility. This work provides a high‐performance synergistic antitumor platform and establishes a B‐modulated metal valence cycling paradigm, paving the way for titanium‐based nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals and School of Chemical Engineering, Dalian University of Technology, 2 Linggong Road, Dalian, P. R. China.
- Department of Gastrointestinal Surgery, Dalian Municipal Central Hospital, 826 Southwest Road, Shahekou District, Dalian, P. R. China.
- School of Bioengineering, Dalian University of Technology, 2 Linggong Road, Dalian, P. R. China.
- Engineering Laboratory of Boric and Magnesic Functional Material Preparative and Applied Technology, 2 Linggong Road, Dalian, Liaoning, P. R. China.
ORCID-Profile: Junwei Ye
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities of China
- Science and Technology Plan Project of Liaoning Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Fang, Y., Li, C., Li, X., Xiu, L., Xiao, D., Wang, M., Sun, L., & Ye, J. (2026). Harnessing Boron‐Mediated Ti Valence Cycling in TiB 2 ‐PEG‐DOX: A Multimodal CDT/PTT/CT Platform for Colorectal Cancer Therapy. Small. https://doi.org/10.1002/smll.202514529
Vancouver
Fang Y, Li C, Li X, Xiu L, Xiao D, Wang M, et al. Harnessing Boron‐Mediated Ti Valence Cycling in TiB 2 ‐PEG‐DOX: A Multimodal CDT/PTT/CT Platform for Colorectal Cancer Therapy. Small. 2026. doi:10.1002/smll.202514529
BibTeX
@article{Fang2026,
author = {Fang, Yueguang and Li, Chenxi and Li, Xinqi and Xiu, Lanling and Xiao, Dingwen and Wang, Miao and Sun, Lin and Ye, Junwei},
title = {Harnessing Boron‐Mediated Ti Valence Cycling in TiB 2 ‐PEG‐DOX: A Multimodal CDT/PTT/CT Platform for Colorectal Cancer Therapy},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202514529}
}
EUVIMED